{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:35:43Z","timestamp":1784543743109,"version":"3.55.0"},"reference-count":132,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Nearly two decades have passed since a paradoxical reaction in the orofacial region to some bone modifying agents and other drugs was recognized, namely medication-related osteonecrosis of the jaw (MRONJ). Purpose: The aim of this manuscript was to critically review published data on MRONJ to provide an update on key terminology, concepts, and current trends in terms of prevention and diagnosis. In addition, our objective was to examine and evaluate the therapeutic options available for MRONJ. Methods: The authors perused the most relevant literature relating to MRONJ through a search in textbooks and published articles included in several databases for the years 2003\u20132021. Results and conclusions: A comprehensive update of the current understanding of these matters was elaborated, addressing these topics and identifying relevant gaps of knowledge. This review describes our updated view of the previous thematic blocks, highlights our current clinical directions, and emphasizes controversial aspects and barriers that may lead to extending the accumulating body of evidence related to this severe treatment sequela.<\/jats:p>","DOI":"10.3390\/jcm10194367","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T20:15:32Z","timestamp":1632514532000},"page":"4367","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9180-4703","authenticated-orcid":false,"given":"Alejandro I.","family":"Lorenzo-Pouso","sequence":"first","affiliation":[{"name":"Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Bag\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Stomatology and Maxillofacial Surgery, Hospital General Universitario de Valencia, 46014 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Bag\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Stomatology and Maxillofacial Surgery, Hospital General Universitario de Valencia, 46014 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2259-7971","authenticated-orcid":false,"given":"Pilar","family":"G\u00e1ndara-Vila","sequence":"additional","affiliation":[{"name":"Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain"},{"name":"ORALRES Group, Health Research Institute of Santiago de Compostela (FIDIS), 15782 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-9908","authenticated-orcid":false,"given":"Cintia M.","family":"Chamorro-Petronacci","sequence":"additional","affiliation":[{"name":"Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain"},{"name":"ORALRES Group, Health Research Institute of Santiago de Compostela (FIDIS), 15782 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Castelo-Baz","sequence":"additional","affiliation":[{"name":"Deparment of Surgery and Medical-Surgical Specialties, Faculty of Medicine and Dentistry, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7405-1834","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Blanco-Carri\u00f3n","sequence":"additional","affiliation":[{"name":"Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain"},{"name":"ORALRES Group, Health Research Institute of Santiago de Compostela (FIDIS), 15782 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Blanco-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Stomatology Service, Provincial Hospital of Pontevedra, 36002 Pontevedra, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-6894","authenticated-orcid":false,"given":"\u00d3scar","family":"\u00c1lvarez-Calder\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Coruna, 15001 La Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3737-9830","authenticated-orcid":false,"given":"Javier","family":"Carballo","sequence":"additional","affiliation":[{"name":"Department of Food Technology, Faculty of Sciences, University of Vigo\u2014Ourense Campus, 32004 Ourense, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2196-9868","authenticated-orcid":false,"given":"Mario","family":"P\u00e9rez-Say\u00e1ns","sequence":"additional","affiliation":[{"name":"Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain"},{"name":"ORALRES Group, Health Research Institute of Santiago de Compostela (FIDIS), 15782 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jbspin.2006.01.025","article-title":"Pathophysiology and natural history of avascular necrosis of bone","volume":"73","author":"Lafforgue","year":"2006","journal-title":"Jt. Bone Spine"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2147\/JIR.S281941","article-title":"Inflammation, bone healing and osteonecrosis: From bedside to bench","volume":"13","author":"Goodman","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: A multicenter retrospective study with propensity score matching analysis","volume":"32","author":"Hayashida","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1302\/0301-620X.68B4.3733842","article-title":"Death of osteocytes. Electron microscopy after in vitro ischaemia","volume":"68","author":"James","year":"1986","journal-title":"J. Bone Jt. Surg. Br."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/15563650701232505","article-title":"Osteonecrosis of the jaw and bisphosphonates: A comparison with white phosphorus, radium, and osteopetrosis","volume":"45","author":"Vance","year":"2007","journal-title":"Clin. Toxicol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1470-2045(06)70704-5","article-title":"Bisphosphonates and phossy-jaw: Breathing new life into an old problem","volume":"7","author":"Ashcroft","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: The first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jcpe.12455","article-title":"Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: A systematic review and meta-analysis","volume":"42","author":"Gaudin","year":"2015","journal-title":"J. Clin. Periodontol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00520-020-05882-3","article-title":"Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: Systematic review and meta-analysis","volume":"29","author":"Srivastava","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"lgz009","DOI":"10.1093\/jncimonographs\/lgz009","article-title":"Medication-related osteonecrosis of the jaws","volume":"2019","author":"Migliorati","year":"2019","journal-title":"J. Natl. Cancer. Inst. Monogr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41415-020-1642-3","article-title":"Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: A review of the literature","volume":"228","author":"Kanwar","year":"2020","journal-title":"Br. Dent. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.joms.2016.07.019","article-title":"Osteonecrosis of the jaw in the absence of antiresorptive or antiangiogenic exposure: A series of 6 cases","volume":"75","author":"Aghaloo","year":"2017","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.coms.2015.06.004","article-title":"The role of antiangiogenic therapy in the development of osteonecrosis of the jaw","volume":"27","author":"Fantasia","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. North. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"104659","DOI":"10.1016\/j.oraloncology.2020.104659","article-title":"New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws","volume":"106","author":"Bennardo","year":"2020","journal-title":"Oral Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.4317\/medoral.23191","article-title":"Review and update on drugs related to the development of osteonecrosis of the jaw","volume":"25","author":"Eguia","year":"2020","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.coms.2011.07.011","article-title":"How can we diagnose and treat osteomyelitis of the jaws as early as possible?","volume":"23","author":"Koorbusch","year":"2011","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1834-7819.2003.tb00011.x","article-title":"Oral ulceration with bone sequestration","volume":"48","author":"Farah","year":"2003","journal-title":"Aust. Dent. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., and Fusco, V. (2020). Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. Int. J. Environ. Res. Public. Health., 17.","DOI":"10.3390\/ijerph17165998"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: A case series","volume":"123","author":"Fedele","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.oraloncology.2012.02.009","article-title":"Bisphosphonate-related osteonecrosis of the jaws: Study of the staging system in a series of clinical cases","volume":"48","author":"Bagan","year":"2012","journal-title":"Oral Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.joms.2009.07.086","article-title":"Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw?","volume":"68","author":"Yarom","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bjoms.2014.09.001","article-title":"Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed","volume":"53","author":"Fedele","year":"2015","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bjoms.2014.04.009","article-title":"Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease","volume":"52","author":"Bedogni","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/odi.13160","article-title":"Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges","volume":"25","author":"Schiodt","year":"2019","journal-title":"Oral Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jnci\/djq516","article-title":"Osteonecrosis of the jaw and the role of macrophages","volume":"103","author":"Pazianas","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current understanding of the pathophysiology of osteonecrosis of the jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Otto, S., Aljohani, S., Fliefel, R., Ecke, S., Ristow, O., Burian, E., Troeltzsch, M., Pautke, C., and Ehrenfeld, M. (2021). Infection as an important factor in medication-related osteonecrosis of the jaw (MRONJ). Medicina, 57.","DOI":"10.3390\/medicina57050463"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: A systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00784-018-2655-z","article-title":"Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw","volume":"23","author":"Zirk","year":"2019","journal-title":"Clin. Oral Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.oooo.2017.11.022","article-title":"Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics","volume":"125","author":"Coropciuc","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1177\/0022034511420430","article-title":"A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw","volume":"90","author":"Mawardi","year":"2011","journal-title":"J. Dent. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jbmr.2992","article-title":"TET3 mediates alterations in the epigenetic marker 5hmC and Akt pathway in steroid-associated osteonecrosis","volume":"32","author":"Zhao","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/jbmr.2577","article-title":"Bisphosphonate induces osteonecrosis of the jaw in diabetic mice via NLRP3\/Caspase-1-dependent IL-1beta mechanism","volume":"30","author":"Zhang","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbmr.2097","article-title":"RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease","volume":"29","author":"Aghaloo","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"644986","DOI":"10.3389\/fcell.2021.644986","article-title":"Membrane transport proteins in osteoclasts: The ins and outs","volume":"9","author":"Ribet","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.joms.2009.07.079","article-title":"Bisphosphonate-related osteonecrosis of the jaw: Is pH the missing part in the pathogenesis puzzle?","volume":"68","author":"Otto","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1016\/j.joms.2010.07.017","article-title":"Osteonecrosis of the jaw: Effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism","volume":"68","author":"Otto","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.oooo.2013.11.490","article-title":"Does an alkaline environment prevent the development of bisphosphonate-related osteonecrosis of the jaw? An experimental study in rats","volume":"117","author":"Dayisoylu","year":"2014","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/0022034520908594","article-title":"Indigenous microbiota protects against inflammation-induced osteonecrosis","volume":"99","author":"Williams","year":"2020","journal-title":"J. Dent. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12967-015-0568-z","article-title":"Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw","volume":"13","author":"Kalyan","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00784-016-1718-2","article-title":"Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw","volume":"20","author":"Kim","year":"2016","journal-title":"Clin. Oral Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jcms.2021.02.018","article-title":"Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis","volume":"49","author":"Schoenhof","year":"2021","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of osteonecrosis of the jaws","volume":"27","author":"Aghaloo","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. North. Am."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Giudice, A., Antonelli, A., Chiarella, E., Baudi, F., Barni, T., and Di Vito, A. (2020). The case of medication-related osteonecrosis of the jaw addressed from a pathogenic point of view: Innovative therapeutic strategies: Focus on the most recent discoveries on oral mesenchymal stem cell-derived exosomes. Pharmaceuticals, 13.","DOI":"10.3390\/ph13120423"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Di Vito, A., Chiarella, E., Baudi, F., Scardamaglia, P., Antonelli, A., Giudice, D., Barni, T., Fortunato, L., and Giudice, A. (2020). Dose-dependent effects of zoledronic acid on human periodontal ligament stem cells: An In Vitro pilot study. Cell Transplant., 29.","DOI":"10.1177\/0963689720948497"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jbmr.4119","article-title":"A drug holiday reduces the frequency and severity of medication-related osteonecrosis of the jaw in a minipig model","volume":"35","author":"Otto","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e03795","DOI":"10.1016\/j.heliyon.2020.e03795","article-title":"Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review","volume":"6","author":"Ottesen","year":"2020","journal-title":"Heliyon"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bone.2019.03.031","article-title":"Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ)","volume":"123","author":"Gkouveris","year":"2019","journal-title":"Bone"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00520-019-04793-2","article-title":"The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and\/or bevacizumab","volume":"28","author":"Papadopoulou","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.joms.2011.02.065","article-title":"Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats","volume":"69","author":"Basi","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4351327","DOI":"10.1155\/2019\/4351327","article-title":"Geranylgeraniol (GGOH) as a mevalonate pathway activator in the rescue of bone cells treated with zoledronic acid: An in Vitro study","volume":"2019","author":"Fliefel","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.2490","article-title":"OPG-Fc but not zoledronic acid discontinuation reverses osteonecrosis of the jaws (ONJ) in mice","volume":"30","author":"Shimamoto","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2231-0762.178742","article-title":"Medication-related osteonecrosis of the jaw: Clinical and practical guidelines","volume":"6","author":"Rosella","year":"2016","journal-title":"J. Int. Soc. Prev. Community Dent."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.bbadis.2015.02.008","article-title":"Rare disease policies to improve care for patients in Europe","volume":"1852","author":"Rodwell","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.joms.2013.06.221","article-title":"Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate","volume":"72","author":"Ulmner","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coms.2015.06.003","article-title":"The frequency of medication-related osteonecrosis of the jaw and its associated risk factors","volume":"27","author":"Dodson","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. North. Am."},{"key":"ref_65","first-page":"e326","article-title":"Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis","volume":"25","author":"Limones","year":"2020","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/odi.12632","article-title":"Time to onset of bisphosphonate-related osteonecrosis of the jaws: A multicentre retrospective cohort study","volume":"23","author":"Fung","year":"2017","journal-title":"Oral Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/jbmr.3017","article-title":"Uncertainty of current algorithm for bisphosphonate-related osteonecrosis of the jaw in population-based studies: A systematic review","volume":"32","author":"Kim","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2018.08.003","article-title":"Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses","volume":"85","author":"Karna","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpor.2014.08.001","article-title":"Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab","volume":"59","author":"Niibe","year":"2015","journal-title":"J. Prosthodont. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/mdn526","article-title":"Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan","volume":"20","author":"Ripamonti","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann. Intern. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","article-title":"Risk factors for osteonecrosis of the jaws: A case-control study from the CONDOR dental PBRN","volume":"90","author":"Barasch","year":"2011","journal-title":"J. Dent. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jcms.2019.03.002","article-title":"Medication-related osteonecrosis of the jaw in a minipig model: Parameters for developing a macroscopic, radiological, and microscopic grading scheme","volume":"47","author":"Nowicki","year":"2019","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.oooo.2015.08.007","article-title":"Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: Report of 5 cases and literature review","volume":"120","author":"Razis","year":"2015","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_76","first-page":"e314","article-title":"Proposal for a preventive protocol for medication-related osteonecrosis of the jaw","volume":"26","year":"2021","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/0022034514560768","article-title":"Diabetes as a risk factor for medication-related osteonecrosis of the jaw","volume":"94","author":"Peer","year":"2015","journal-title":"J. Dent. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/odi.12490","article-title":"BRONJ in patients with rheumatoid arthritis: A multicenter case series","volume":"22","author":"Bedogni","year":"2016","journal-title":"Oral Dis."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"On, S.W., Cho, S.W., Byun, S.H., and Yang, B.E. (2021). Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: A narrative review on new molecular and cellular therapeutic approaches. Antioxidants, 10.","DOI":"10.3390\/antiox10050680"},{"key":"ref_80","first-page":"e466","article-title":"A multicenter observational study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy","volume":"26","author":"Fusco","year":"2020","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","article-title":"Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention","volume":"125","author":"Owosho","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Japanese Allied Committee on Osteonecrosis of the Jaw, Yoneda, T., Hagino, H., Sugimoto, T., Ohta, H., Takahashi, S., Soen, S., Taguchi, A., Nagata, T., and Urade, M. (2017). Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J. Bone Miner. Metab., 35, 6\u201319.","DOI":"10.1007\/s00774-016-0810-7"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.morpho.2020.11.008","article-title":"Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management","volume":"105","author":"Fauvel","year":"2021","journal-title":"Morphologie"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.ijom.2019.04.014","article-title":"Genetic predisposition for medication-related osteonecrosis of the jaws: A systematic review","volume":"48","author":"Pullano","year":"2019","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_85","first-page":"e26","article-title":"Biomarkers to predict the onset of biphosphonate-related osteonecrosis of the jaw: A systematic review","volume":"24","author":"Bagan","year":"2019","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.oooo.2019.02.014","article-title":"Association between biomarkers and medication-related osteonecrosis of the jaws: A systematic review","volume":"127","author":"Moraschini","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.adaj.2019.03.006","article-title":"Serum C-terminal cross-linking telopeptide level as a predictive biomarker of osteonecrosis after dentoalveolar surgery in patients receiving bisphosphonate therapy: Systematic review and meta-analysis","volume":"150","author":"Awad","year":"2019","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.adaj.2017.04.002","article-title":"Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis","volume":"148","author":"Sgro","year":"2017","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcms.2020.01.014","article-title":"Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review","volume":"48","author":"Fortunato","year":"2020","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jcms.2012.11.023","article-title":"The observational study of delayed wound healing after tooth extraction in patients receiving oral bisphosphonate therapy","volume":"41","author":"Hasegawa","year":"2013","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/sj.leu.2404682","article-title":"A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma","volume":"21","author":"Corso","year":"2007","journal-title":"Leukemia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bjoms.2020.03.010","article-title":"Medication-related osteonecrosis of the jaws and quality of life: Review and structured analysis","volume":"58","author":"Murphy","year":"2020","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_94","first-page":"250","article-title":"Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review","volume":"21","author":"Limeres","year":"2016","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1601-0825.2009.01581.x","article-title":"Dental management of patients at risk of osteochemonecrosis of the jaws: A critical review","volume":"15","author":"Fedele","year":"2009","journal-title":"Oral Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","article-title":"Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management","volume":"102","author":"Ruggiero","year":"2006","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1601-0825.2012.01903.x","article-title":"Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"18","author":"Bedogni","year":"2012","journal-title":"Oral Dis."},{"key":"ref_98","first-page":"20170290","article-title":"Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws?","volume":"47","author":"Shimamoto","year":"2018","journal-title":"Dentomaxillofac. Radiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijom.2016.09.025","article-title":"Grade of sclerosis in the contralateral mandibular area in osteonecrosis of the jaws","volume":"46","author":"Bagan","year":"2017","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.oooo.2013.10.010","article-title":"Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: A retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system","volume":"117","author":"Schiodt","year":"2014","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.joms.2009.03.005","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: Bone scintigraphy as an early indicator","volume":"67","author":"Khoury","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joms.2008.02.012","article-title":"Nonexposed bisphosphonate-related osteonecrosis of the jaws: Another clinical variant?","volume":"66","author":"Junquera","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2010.195","article-title":"Osteonecrosis of the jaw and bisphosphonates in cancer: A narrative review","volume":"7","author":"Migliorati","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jcms.2018.12.014","article-title":"Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study","volume":"47","author":"Ristow","year":"2019","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdn630","article-title":"Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome","volume":"20","author":"Claeys","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11005\/jbm.2015.22.4.151","article-title":"Medication related osteonecrosis of the jaw: 2015 position statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons","volume":"22","author":"Kim","year":"2015","journal-title":"J. Bone Metab."},{"key":"ref_107","first-page":"336","article-title":"Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates","volume":"12","author":"Bagan","year":"2007","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00784-020-03595-9","article-title":"Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ)","volume":"25","author":"Ewald","year":"2021","journal-title":"Clin. Oral Investig."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/fon.13.211","article-title":"Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents","volume":"10","author":"Campisi","year":"2014","journal-title":"Future Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"31604","DOI":"10.1038\/srep31604","article-title":"The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection","volume":"6","author":"Russmueller","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.joms.2018.05.025","article-title":"Nonsurgical management of medication-related osteonecrosis of the jaws using local wound care","volume":"76","author":"Hadaya","year":"2018","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Pippi, R., Giuliani, U., Tenore, G., Pietrantoni, A., and Romeo, U. (2021). What is the risk of developing medication-related osteonecrosis in patients with extraction sockets left to heal by secondary intention? A retrospective case series study. J. Oral Maxillofac. Surg.","DOI":"10.1016\/j.joms.2021.05.031"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/odi.12764","article-title":"Medication-related osteonecrosis of the jaw: Surgical or non-surgical treatment?","volume":"24","author":"Favia","year":"2018","journal-title":"Oral Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/jop.12963","article-title":"Association between periodontitis and medication-related osteonecrosis of the jaw: A systematic review and meta-analysis","volume":"49","author":"Carballo","year":"2020","journal-title":"J. Oral Pathol. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.joms.2015.09.024","article-title":"Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw","volume":"73","author":"Ruggiero","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.joms.2020.05.037","article-title":"Can surgical management improve resolution of medication-related osteonecrosis of the jaw at early stages? A prospective cohort study","volume":"78","author":"Giudice","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_117","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","article-title":"The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw","volume":"111","author":"Wilde","year":"2011","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tripleo.2010.05.048","article-title":"How to optimize the preparation of leukocyte- and platelet-rich fibrin (L-PRF, Choukroun\u2019s technique) clots and membranes: Introducing the PRF Box","volume":"110","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcms.2016.05.004","article-title":"Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review","volume":"44","author":"Tobias","year":"2016","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_121","first-page":"2662","article-title":"Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review","volume":"25","author":"Goker","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_122","first-page":"267","article-title":"Osteonecrosis of the jaws in 194 patients who have undergone intravenous bisphosphonate therapy in Spain","volume":"20","year":"2015","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/SCS.0000000000000846","article-title":"Surgical neurolysis for the treatment of neuropathic pain in 2 postmenopausal women with mandibular necrosis resulting from oral bisphosphonates","volume":"25","year":"2014","journal-title":"J. Craniofac. Surg."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/odi.12992","article-title":"Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series","volume":"25","author":"Aljohani","year":"2019","journal-title":"Oral Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.oooo.2020.10.018","article-title":"Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): A retrospective single-center study","volume":"131","author":"Otto","year":"2021","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10006-016-0597-7","article-title":"Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites","volume":"21","author":"Blus","year":"2017","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.joms.2017.10.024","article-title":"Can autofluorescence guide surgeons in the treatment of medication-related osteonecrosis of the jaw? A prospective feasibility study","volume":"76","author":"Giudice","year":"2018","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"102003","DOI":"10.1016\/j.pdpdt.2020.102003","article-title":"Fluorescence-guided surgical management of medication-related osteonecrosis of the jaws","volume":"32","author":"Tomo","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bjoms.2007.03.016","article-title":"Nd:YAG laser biostimulation of bisphosphonate-associated necrosis of the jawbone with and without surgical treatment","volume":"45","author":"Vescovi","year":"2007","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/pho.2014.3742","article-title":"Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: A retrospective analysis of 11 cases","volume":"32","author":"Altay","year":"2014","journal-title":"Photomed. Laser Surg."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.ijom.2015.07.018","article-title":"Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: Preliminary findings","volume":"44","author":"Kakehashi","year":"2015","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/jbmr.3237","article-title":"Short-term teriparatide and recombinant human bone morphogenetic protein-2 for regenerative approach to medication-related osteonecrosis of the Jaw: A preliminary study","volume":"32","author":"Jung","year":"2017","journal-title":"J. Bone Miner. Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/19\/4367\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:04:36Z","timestamp":1760166276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/19\/4367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":132,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["jcm10194367"],"URL":"https:\/\/doi.org\/10.3390\/jcm10194367","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}